financetom
Market
financetom
/
Market
/
Oil prices extend gains after OPEC+ output cut plan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil prices extend gains after OPEC+ output cut plan
Oct 6, 2022 9:26 PM

Oil prices rose on Friday, continuing an upward trend after OPEC+ this week agreed to tighten global supply with a deal to cut production targets by 2 million barrels per day (bpd).

Share Market Live

NSE

The cut from the Organization of Petroleum Exporting Countries and allies including Russia, together known as OPEC+, is its largest reduction since 2020 and comes ahead of a European Union embargo on Russian oil. The decision would squeeze supplies in an already tight market, adding to inflation.

Brent crude futures rose 19 cents to $94.61 a barrel by 00:02 GMT. WTI crude futures rose 24 cents to $88.69 a barrel, after earlier hitting $89.37 per barrel, the highest since Sept. 14.

US President Joe Biden expressed disappointment on Thursday over OPEC+'s plans and he and officials said the United States was looking at all possible alternatives to keep prices from rising. Some of those options include releasing more oil from the Strategic Petroleum Reserve or exploring a curb on energy exports by US companies.

Goldman Sachs has raised its oil price forecast for this year and 2023, as the US bank expects OPEC+'s output cut to be "very bullish" for prices going forward. It raised its 2022 Brent price forecast to $104 per barrel from $99 per barrel and 2023 forecast to $110 per barrel from $108 per barrel.

Also Read: Wall Street falls ahead of September's jobs report

(Edited by : Sangam Singh)

First Published:Oct 7, 2022 6:26 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
This Little-Known Buy Now, Pay Later Stock Is Up 9,998%: Analysts Think It Still Has Room To Run
This Little-Known Buy Now, Pay Later Stock Is Up 9,998%: Analysts Think It Still Has Room To Run
Jun 17, 2025
Buy Now, Pay Later company, Sezzle Inc. ( SEZL ) is hardly on Wall Street’s radar despite posting an impressive 9,998% rally since its public listing just two years ago. What Happened: On Monday, the Schwab Network’s senior market correspondent, George Tsilis, discussed the overlooked fintech company, highlighting the key reasons for its remarkable 991% gains over the past year,...
Solar stocks plunge on Senate proposal to phase out tax credits by 2028
Solar stocks plunge on Senate proposal to phase out tax credits by 2028
Jun 17, 2025
(Reuters) -U.S. solar stocks tumbled on Tuesday after a Senate panel proposed phasing out solar and wind tax credits by 2028, as part of changes to President Donald Trump's sweeping tax-and-spending bill. Solar inverter maker Enphase Energy and solar panel manufacturer First Solar slid 27.2% and 19.3%, respectively, among the biggest decliners on the benchmark S&P 500. Other solar panel...
US STOCKS-Wall St indexes edge lower as Middle East conflict persists
US STOCKS-Wall St indexes edge lower as Middle East conflict persists
Jun 17, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * Indexes down: Dow 0.17%, S&P 500 0.33%, Nasdaq 0.36% * Solar stocks down as Senate proposes to phase out tax credits * Eli Lilly ( LLY ) to acquire Verve Therapeutics ( VERV ) for up to $1.3 bln...
Top Midday Stories: Shares Decline Amid Unease Over Israel-Iran Conflict; Retail Sales Fall More Than Expected in May
Top Midday Stories: Shares Decline Amid Unease Over Israel-Iran Conflict; Retail Sales Fall More Than Expected in May
Jun 17, 2025
11:50 AM EDT, 06/17/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday it has agreed to acquire Verve Therapeutics ( VERV ) for up to $1.3 billion in an effort to advance its gene-editing therapies for cardiovascular disease. Lilly will pay $10.50 per share in cash, with the potential for additional payments based on clinical milestones, the companies...
Copyright 2023-2025 - www.financetom.com All Rights Reserved